Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2012-02-09
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 16
- Registration Number
- NCT00938951
Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2010-05-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 76
- Registration Number
- NCT00934622
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Acute Clinical Evaluation of Multi-purpose Solutions (MPS) in Soft Contact Lens Wearers
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-29
- Last Posted Date
- 2012-09-10
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 278
- Registration Number
- NCT00929487
- Locations
- 🇬🇧
Visioncare Research, Ltd., Farnham, Surrey, United Kingdom
Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) Patients
- First Posted Date
- 2009-06-29
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00929747
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-26
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 155
- Registration Number
- NCT00928590
DuoTrav APS Versus XALACOM® in Ocular Surface Health
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2012-07-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 240
- Registration Number
- NCT00912054
- Locations
- 🇧🇪
Cliniques Universitaires Saint Luc, Brussels, Belgium
An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 452
- Registration Number
- NCT00901693
Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 434
- Registration Number
- NCT00892762
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 765
- Registration Number
- NCT00893139
Geographic Atrophy Treatment Evaluation
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2014-07-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 772
- Registration Number
- NCT00890097
© Copyright 2024. All Rights Reserved by MedPath